Pre-discharge Flu Vaccine for patients with acute heart problems

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This investigator-initiated, single-center study enrolls adults hospitalized for acute cardiac conditions such as myocardial infarction or acute heart failure and randomizes them to receive an influenza vaccine within 24 hours before discharge. The open-label design compares vaccination timing at discharge versus standard care, aiming to see if pre-discharge vaccination increases protection against flu-related complications. Eligible patients are planning to go home within 48 hours of finishing in-hospital care and have not yet received a flu vaccine for the current season. Outcomes focus on feasibility and potential reduction in recurrent cardiovascular events linked to influenza infection. The study is conducted at Jan Mikulicz Radecki University Hospital in Wroclaw, led by Wroclaw Medical University.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Acute cardiac hospitalization,
* Planned discharge home within the next 48 hours following completion of in-hospital treatment,
* No prior influenza vaccination for the current influenza season.

Exclusion Criteria:

* History of a severe adverse reaction to influenza vaccination,
* Allergy to any component of the vaccine to be administered,
* Discharge to another hospital for continuation of treatment or discharge to a long-term care facility,
* Antibiotic therapy to be continued after discharge.

Where it's running

• Jan Mikulicz Radecki University Hospital in Wroclaw
  Wroclaw, Poland Recruiting

Study contacts

• Study coordinator: Piotr Kübler Kübler, Professor
• Email: piotr.kubler@umw.edu.pl
• Phone: 48717364240

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• Disrupted congestion in acute heart failure: can ultrasound at discharge predict readmission and death

  This study tests whether ultrasound checks of congestion at discharge can predict which patients with acute heart failure are more likely to be readmitted or die within 90 days.

  Recruiting University of Aarhus · Aarhus and 2 other locations · NCT07682298

• Digital cardiac rehab to help heart attack patients improve function

  A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.

  Recruiting Cairo University · Minya, Minya Province · NCT07867197

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Innate Immune Cells and Early Fibrotic Repair After a Heart Attack

  This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.

  Recruiting Shanghai 10th People's Hospital · Shanghai · NCT07764588

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.